Ascentage Pharma Group International
HKEX:6855.HK
44.2 (HKD) • At close November 12, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) HKD.
2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | |
---|---|---|---|---|---|---|---|---|
Assets: | ||||||||
Current Assets: | ||||||||
Cash & Cash Equivalents
| 1,069.296 | 1,492.24 | 1,743.821 | 1,024.4 | 882.457 | 957.088 | 14.821 | 294.529 |
Short Term Investments
| 6.557 | 11.905 | 4.145 | 3.026 | 2.599 | 14.399 | 384.168 | 157.39 |
Cash and Short Term Investments
| 1,069.296 | 1,504.145 | 1,747.966 | 1,027.426 | 885.056 | 971.487 | 398.989 | 451.919 |
Net Receivables
| 145.893 | 54.356 | 53.968 | 0 | 0 | 0 | 0 | 0.556 |
Inventory
| 16.167 | 9.448 | 3.93 | 0 | 0 | 0 | 0 | -157.39 |
Other Current Assets
| 81.728 | 68.539 | 79.416 | 51.618 | 24.049 | 18.732 | 15.724 | 11.224 |
Total Current Assets
| 1,344.178 | 1,636.488 | 1,885.28 | 1,079.044 | 909.105 | 990.219 | 414.713 | 463.699 |
Non-Current Assets: | ||||||||
Property, Plant & Equipment, Net
| 957.232 | 648.722 | 844.368 | 477.001 | 142.287 | 33.992 | 25.33 | 4.513 |
Goodwill
| 24.694 | 24.694 | 24.694 | 24.694 | 24.694 | 24.694 | 24.694 | 24.694 |
Intangible Assets
| 85.446 | 84.304 | 60.411 | 66.405 | 72.192 | 108.528 | 80.709 | 87.129 |
Goodwill and Intangible Assets
| 110.14 | 108.998 | 85.105 | 91.099 | 96.886 | 133.222 | 105.403 | 111.823 |
Long Term Investments
| 18.949 | 18.531 | 27.845 | 31.774 | 32.191 | 45.119 | -353.84 | -144.839 |
Tax Assets
| 59.842 | 54.294 | 51.648 | 0 | 0 | 0 | 0 | 0 |
Other Non-Current Assets
| 10.052 | -54.294 | -51.648 | -599.874 | -271.364 | 26.824 | 390.058 | 158.145 |
Total Non-Current Assets
| 1,156.215 | 776.251 | 957.318 | 599.874 | 271.364 | 239.157 | 166.951 | 129.642 |
Total Assets
| 2,500.393 | 2,830.261 | 2,940.06 | 1,731.039 | 1,205.05 | 1,229.376 | 581.664 | 593.341 |
Liabilities & Equity: | ||||||||
Current Liabilities: | ||||||||
Account Payables
| 72.445 | 95.559 | 70.861 | 23.361 | 13.084 | 5.081 | 3.822 | 0.156 |
Short Term Debt
| 616.404 | 518.383 | 49.451 | 50.561 | 92.194 | 37.587 | 2.019 | 0.358 |
Tax Payables
| 8.389 | 7.179 | 3.279 | 5.984 | 1.6 | 1.004 | 0.57 | 0.137 |
Deferred Revenue
| 0 | -518.383 | -49.451 | -50.561 | -92.194 | 0 | 0 | 0 |
Other Current Liabilities
| 236.935 | 260.031 | 237.518 | 196.242 | 95.184 | 61.597 | 73.124 | 76.967 |
Total Current Liabilities
| 934.173 | 881.152 | 361.109 | 276.148 | 202.062 | 105.269 | 79.535 | 77.618 |
Non-Current Liabilities: | ||||||||
Long Term Debt
| 1,179.191 | 1,274.344 | 1,034.839 | 479.134 | 9.211 | 4.457 | 2.879 | 0.472 |
Deferred Revenue Non-Current
| 287.549 | 218.625 | 243.279 | 40.207 | 35.097 | 27.032 | 15.96 | 8.737 |
Deferred Tax Liabilities Non-Current
| 10.549 | 12.151 | 13.753 | 15.355 | 16.957 | 18.559 | 20.161 | 21.763 |
Other Non-Current Liabilities
| 316.397 | -9.144 | -8.247 | -6.079 | 103.302 | 2,131.236 | 631.047 | 529.857 |
Total Non-Current Liabilities
| 1,495.588 | 1,265.2 | 1,026.592 | 473.055 | 112.513 | 2,135.693 | 633.926 | 530.329 |
Total Liabilities
| 2,429.761 | 2,421.603 | 1,705.323 | 884.418 | 314.575 | 2,240.962 | 713.461 | 607.947 |
Equity: | ||||||||
Preferred Stock
| 504.461 | 518.514 | 550.949 | 509.812 | 467.503 | 615.817 | 0 | 0 |
Common Stock
| 0.197 | 0.18 | 0.178 | 0.154 | 0.142 | 0.063 | 0 | 0 |
Retained Earnings
| -5,365.122 | -4,439.485 | -3,556.561 | -2,774.137 | -2,096.531 | -615.817 | -270.51 | -151.996 |
Accumulated Other Comprehensive Income/Loss
| -504.461 | -518.514 | -550.949 | -509.812 | -467.503 | -14.757 | -7.183 | -3.354 |
Other Total Stockholders Equity
| 5,929.803 | 4,329.449 | 5,342.069 | 4,130.416 | 2,519.361 | 43.694 | 145.896 | 140.744 |
Total Shareholders Equity
| 60.417 | 408.658 | 1,234.737 | 846.621 | 890.475 | -1,011.586 | -131.797 | -14.606 |
Total Equity
| 70.632 | 408.658 | 1,234.737 | 846.621 | 890.475 | -1,011.586 | -131.797 | -14.606 |
Total Liabilities & Shareholders Equity
| 2,500.393 | 2,830.261 | 2,940.06 | 1,731.039 | 1,205.05 | 1,229.376 | 581.664 | 593.341 |